Clinical evidence, practice guidelines, and β-blocker utilization before major noncardiac surgery

Circulation: Cardiovascular Quality and Outcomes

Volumn 5, Issue 4, 2012, Pages 558-565

  Wijeysundera, Duminda N ^a,b,c,d   Mamdani, Muhammad ^a,b,c,d,e   Laupacis, Andreas ^a,c,d,f   Fleisher, Lee A ^g,i   Beattie, W Scott ^b   Johnson, Sindhu R ^d,h   Kolstad, Jonathan ^i,j   Neuman, Mark D ^g,i  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h MOUNT SINAI HOSPITAL   (Canada)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

blockers; Coronary artery disease; Health services research; Surgery

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; METOPROLOL;

AGED; ANGINA PECTORIS; ARTICLE; CANADA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CLINICAL PRACTICE; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DRUG USE; ELECTIVE SURGERY; EVIDENCE BASED MEDICINE; HEART ARRHYTHMIA; HEART DEATH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; POPULATION RESEARCH; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; STROKE; UNSTABLE ANGINA PECTORIS;

ADRENERGIC BETA-ANTAGONISTS; AGED; ATTITUDE OF HEALTH PERSONNEL; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; DRUG UTILIZATION; EVIDENCE-BASED MEDICINE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES RESEARCH; HEART DISEASES; HUMANS; LINEAR MODELS; ODDS RATIO; ONTARIO; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE; SURGICAL PROCEDURES, OPERATIVE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84864581713     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.112.965632     Document Type: Article

References (43)

1. Djokovic JL, Hedley-Whyte J. Prediction of outcome of surgery and anesthesia in patients over 80. JAMA. 1979;242:2301-2306.
2. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF. 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade incorporated into the ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009;120:e169-e276.
3. Goldman L, Caldera DL, Nussbaum SR, Southwick FS, Krogstad D, Murray B, Burke DS, O'Malley TA, Goroll AH, Caplan CH, Nolan J, Carabello B, Slater EE. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977;297:845-850.
4. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med. 1996;335:1713-1720.
5. P Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL, Blankensteijn JD, Baars HF, Yo TI, Trocino G, Vigna C, Roelandt JR, van Urk H. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med. 1999;341:1789-1794.
6. Birkmeyer JD, Dimick JB. The Leapfrog Group's Patient Safety Practices, 2003: The Potential Benefits of Universal Adoption. Washington, DC: Leapfrog Group; 2004.
7. Leape LL, Berwick DM, Bates DW. What practices will most improve safety? Evidence-based medicine meets patient safety. JAMA. 2002;288:501-507.
8. National Quality Forum. Safe Practices for Better Healthcare: 2006 Update. Washington, DC: National Quality Forum; 2006.
9. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleischmann KE, Fleisher LA, Froehlich JB, Gusberg RJ, Leppo JA, Ryan T, Schlant RC, Winters WLJ, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SCJ. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guideline. Circulation. 2002;105:1257-1267.
10. POBBLE Trial Investigators. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: results of a randomized double-blind controlled trial. J Vasc Surg. 2005;41:602-609.
11. Juul AB, Wetterslev J, Gluud C, Kofoed-Enevoldsen A, Jensen G, Callesen T, Nørgaard P, Fruergaard K, Bestle M, Vedelsdal R, Miran A, Jacobsen J, Roed J, Mortensen M-B, Jørgensen L, Jørgensen J, Rovsing M-L, Petersen PL, Pott F, Haas M, Albret R, Nielsen LL, Johansson G, Stjernholm P, Mølgaard Y, Foss NB, Elkjaer J, Dehlie B, Boysen K, Zaric D, Munksgaard A, Madsen JB, Øberg B, Khanykin B, Blemmer T, Yndgaard S, Perko G, Wang LP, Winkel P, Hilden J, Jensen P, Salas N, and the DIPOM Group. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ. 2006;332:1482.
12. Yang H, Raymer K, Butler R, Parlow J, Roberts R. The effects of perioperative beta-blockade: results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J. 2006;152:983-990.
13. Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353:349-361.
14. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Robb JF, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B. ACC/AHA 2006 guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2006;113:2662-2674.
15. POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371:1839-1847.
16. Technical Supplement: Health Care in Canada 2005. Ottawa, ON, Canada: Canadian Institute for Health Information; 2005.
17. Bourne RB, DeBoer D, Hawker G, Kreder H, Mahomed N, Paterson JM, Warner S, Williams J. Chapter 5: Total Hip and Knee Replacement. In: Tu JV, Pinfold SP, McColgan P, Laupacis A, eds. Access to Health Service in Ontario: ICES Atlas. Toronto, ON, Canada: Institute for Clinical Evaluative Sciences; 2005;114-115.
18. Juurlink D, Preya C, Croxford R, Chong A, Austin P, Tu J, Laupacis A. Canadian Institute for Health Information Discharge Abstract Database: A Validation Study. ICES Investigative Report. Toronto, ON, Canada: Institute for Clinical Evaluative Sciences; 2006.
19. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, Sugarbaker DJ, Donaldson MC, Poss R, Ho KK, Ludwig LE, Pedan A, Goldman L. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043-1049.
20. Auerbach A, Goldman L. Assessing and reducing the cardiac risk of noncardiac surgery. Circulation. 2006;113:1361-1376.
21. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130-1139.
22. Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002;25:512-516.
23. Levy AR, O'Brien BJ, Sellors C, Grootendorst P, Willison D. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol. 2003;10:67-71.
24. Flu W-J, van Kuijk J-P, Chonchol M, Winkel TA, Verhagen HJM, Bax JJ, Poldermans D. Timing of pre-operative beta-blocker treatment in vascular surgery patients: influence on post-operative outcome. J Am Coll Cardiol. 2010;56:1922-1929.
25. Wijeysundera DN, Austin PC, Hux JE, Beattie WS, Buckley DN, Laupacis A. Development of an algorithm to identify preoperative medical consultations using administrative data. Med Care. 2009;47: 1258-1264.
26. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med. 2004;351: 543-551.
27. Helfenstein U. Box-Jenkins modelling in medical research. Stat Methods Med Res. 1996;5:3-22.
28. Eagle KA, Brundage BH, Chaitman BR, Ewy GA, Fleisher LA, Hertzer NR, Leppo JA, Ryan T, Schlant RC, Spencer WH, Spittell JA, Twiss RD, Ritchie JL, Cheitlin MD, Gardner TJ, Garson A, Lewis RP, Gibbons RJ, O'Rourke RA, Ryan TJ. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 1996;93:1278-1317.
29. Dickey D, Fuller W. Distribution of the estimators for autoregressive time series with a unit root. J Am Stat Assoc. 1979;74:427-431.
30. Ljung GM, Box GEP. Measure of lack of fit in time-series models. Biometrika. 1978;65:297-303.
31. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27:299-309.
32. Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts: treatments for myocardial infarction. JAMA. 1992;268:240-248.
33. Berwick DM. Disseminating innovations in health care. JAMA. 2003;289:1969-1975.
34. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458-1465.
35. Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients' care. Lancet. 2003;362:1225-1230.
36. Dixon-Woods M, Amalberti R, Goodman S, Bergman B, Glasziou P. Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new. BMJ Qual Saf. 2011;20(Suppl 1): i47-i51.
37. Greenhalgh T, Robert G, Macfarlane F, Bate P, Kyriakidou O. Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q. 2004;82:581-629.
38. Feldman RD. The 1999 Canadian recommendations for the management of hypertension: on behalf of the Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension. Can J Cardiol. 1999;15(Suppl G):57G-64G.
39. Campbell NRC, Tu K, Brant R, Duong-Hua M, McAlister FA, for the Canadian Hypertension Education Program Outcomes Research Task Force. The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends. Hypertension. 2006;47:22-28.
40. Devereaux PJ, Beattie WS, Choi PT, Badner NH, Guyatt GH, Villar JC, Cina CS, Leslie K, Jacka MJ, Montori VM, Bhandari M, Avezum A, Cavalcanti AB, Giles JW, Schricker T, Yang H, Jakobsen CJ, Yusuf S. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ. 2005;331:313-321.
41. Ellenberger C, Tait G, Beattie WS. Chronic b blockade is associated with a better outcome after elective noncardiac surgery than acute b blockade: a single-center propensity-matched cohort study. Anesthesiology. 2011;114:817-823.
42. NICE-SUGAR Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283-1297.
43. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-1367.